Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms

Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms

Despite the advances in understanding the biology of hematologic neoplasms which has resulted in the approval of new drugs, the therapeutic options are still scarce for relapsed/refractory patients. Eribulin is a unique microtubule inhibitor that is currently being used in the therapy for metastatic...

Full description

Bibliographic Details
Main Authors: Hugo Passos Vicari, Keli Lima, Leticia Veras Costa-Lotufo, João Agostinho Machado-Neto
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
eribulin
microtubule dynamics
acute leukemias
drug resistance
Online Access:https://www.mdpi.com/2072-6694/14/24/6080

Internet

https://www.mdpi.com/2072-6694/14/24/6080

Similar Items